We are live on ! Find out more
WP

Woodline Partners Portfolio holdings

AUM $26.4B
1-Year Est. Return 44.85%
This Fund
S&P 500
This Quarter Est. Return
+4.94%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$6.98B
AUM Growth
+$857M
Cap. Flow
+$784M
Cap. Flow %
11.24%
Top 10 Hldgs %
16.48%
Holding
878
New
205
Increased
124
Reduced
98
Closed
184

Top Buys

Rank Stock Value
1
QRVO icon
Qorvo
QRVO
+$153M
2
ASML icon
ASML
ASML
+$117M
3
RVMD icon
Revolution Medicines
RVMD
+$58.1M
4
META icon
Meta Platforms (Facebook)
META
+$49.6M
5
ISRG icon
Intuitive Surgical
ISRG
+$48.5M

Top Sells

Rank Stock Value
1
TER icon
Teradyne
TER
+$132M
2
QCOM icon
Qualcomm
QCOM
+$77.3M
3
ABT icon
Abbott
ABT
+$69.2M
4
BKNG icon
Booking.com
BKNG
+$67.7M
5
KLAC icon
KLA
KLAC
+$63.2M

Sector Composition

Rank Sector Weight
1 Healthcare 41.18%
2 Technology 29.45%
3 Communication Services 6.73%
4 Industrials 6.43%
5 Financials 4.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PCRX icon
276
Pacira BioSciences
PCRX
$980M
$5.28M 0.08%
+87,800
New +$4.84M
EXFY icon
277
Expensify
EXFY
$190M
$5.19M 0.07%
+117,996
New +$4.8M
VRDN icon
278
Viridian Therapeutics
VRDN
$2.28B
$5.09M 0.07%
+257,670
New +$4.8M
HRTX icon
279
Heron Therapeutics
HRTX
$94.8M
$5.09M 0.07%
+557,799
New +$5.7M
AKBA icon
280
Akebia Therapeutics
AKBA
$359M
$5.04M 0.07%
2,231,966
-91,551
-4% -$250K
BLSA
281
DELISTED
BCLS Acquisition Corp. Class A Ordinary Shares
BLSA
$5.02M 0.07%
512,616
– –
TDG icon
282
TransDigm Group
TDG
$69.6B
$4.95M 0.07%
+7,780
New +$4.87M
REVHU
283
DELISTED
Revolution Healthcare Acquisition Corp. SAIL Units
REVHU
$4.95M 0.07%
500,000
– –
CVII
284
DELISTED
Churchill Capital Corp VII Class A Common Stock
CVII
$4.92M 0.07%
500,000
– –
AUTL
285
Autolus Therapeutics
AUTL
$506M
$4.87M 0.07%
+937,961
New +$5.63M
AAQC
286
DELISTED
Accelerate Acquisition Corp
AAQC
$4.86M 0.07%
500,000
– –
TPTX
287
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$4.8M 0.07%
100,644
+50,416
+100% +$2.25M
TBIO
288
DELISTED
Telesis Bio, Inc. Common Stock
TBIO
$4.79M 0.07%
24,662
-3,500
-12% -$545K
VISN
289
Vistance Networks Inc
VISN
$2.8B
$4.69M 0.07%
424,968
-642,206
-60% -$7.04M
VTRS icon
290
Viatris
VTRS
$20.6B
$4.69M 0.07%
346,500
– –
COCH icon
291
Envoy Medical
COCH
$54.3M
$4.63M 0.07%
475,000
– –
KNTE
292
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$4.61M 0.07%
260,276
– –
NXTC icon
293
NextCure
NXTC
$20.5M
$4.54M 0.07%
+63,000
New +$5.27M
EJFA
294
DELISTED
EJF Acquisition Corp. Class A Ordinary Share
EJFA
$4.51M 0.06%
454,154
+22,577
+5% +$224K
EPAY
295
DELISTED
Bottomline Technologies Inc
EPAY
$4.5M 0.06%
+79,655
New +$3.73M
QTEK
296
DELISTED
QualTek Services Inc. Class A Common Stock
QTEK
$4.47M 0.06%
450,000
– –
GRNA
297
DELISTED
GreenLight Biosciences Holdings, PBC Common Stock
GRNA
$4.46M 0.06%
450,000
– –
KROS icon
298
Keros Therapeutics
KROS
$198M
$4.46M 0.06%
76,212
-111,623
-59% -$5.57M
FMAC
299
DELISTED
FirstMark Horizon Acquisition Corp.
FMAC
$4.45M 0.06%
+450,000
New +$4.44M
BRDG
300
DELISTED
Bridge Investment Group
BRDG
$4.44M 0.06%
177,648
-87,500
-33% -$1.75M
10 11
12
13 14

Similar funds

PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
TCIIS
TIAA-CREF Individual & Institutional Services New York $26B AUM
WorldQuant Millennium Advisors
WorldQuant Millennium Advisors New York $25.9B AUM 22.07% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $27B AUM 24.49% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
UIM
USS Investment Management London, United Kingdom $25.6B AUM 30.22% 1-Year Est. Return
VAI
Vanguard Advisers Inc Malvern, Pennsylvania $25.5B AUM

Woodline Partners's Q4 2021 Portfolio in Review

As of Q4 2021, Woodline Partners held 878 positions worth $6.98B, up 14% from $6.12B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Woodline Partners deployed $784M of net new capital in Q4 2021, opening 205 new positions and adding to 124 existing holdings. Its largest new stake was Qorvo: 963,210 shares worth $151M.

By sector, the portfolio is most concentrated in Healthcare at 41% of assets, down from 46% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was KLA, an estimated $63.2M trimmed.

  • Woodline Partners's largest Q4 2021 buy was Qorvo: 963,210 shares worth $151M.
  • Woodline Partners added most to ASML in Q4 2021, an estimated $117M increase.
  • Woodline Partners's biggest Q4 2021 reduction was KLA, cutting an estimated $63.2M.
  • Woodline Partners fully exited Teradyne in Q4 2021, selling an estimated $132M.
  • Woodline Partners's ten largest holdings make up 16% of its $6.98B portfolio in Q4 2021.
  • Woodline Partners opened 205 new positions and closed 184 in Q4 2021.
  • Woodline Partners's portfolio value rose 14% quarter-over-quarter to $6.98B.

Based on Woodline Partners's 13F filing for Q4 2021, filed 14 Feb 2022.